Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2017 1
2018 1
2019 3
2020 5
2021 4
2022 4
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean xiaoqing tu (19 results)?
TAZ2 truncation confers overactivation of p300 and cellular vulnerability to HDAC inhibition.
Xu L, Xuan H, He W, Zhang L, Huang M, Li K, Wen H, Xu H, Shi X. Xu L, et al. Nat Commun. 2023 Sep 2;14(1):5362. doi: 10.1038/s41467-023-41245-2. Nat Commun. 2023. PMID: 37660055 Free PMC article.
Our study reveals a function of the TAZ2 domain in HAT autoinhibitory regulation and provides a potential therapeutic strategy for the treatment of cancers harboring p300/CBP TAZ2 truncations....
Our study reveals a function of the TAZ2 domain in HAT autoinhibitory regulation and provides a potential therapeutic strategy for th …
Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial.
Weng D, Xiong H, Zhu C, Wan X, Chen Y, Wang X, Zhang Y, Jiang J, Zhang X, Gao Q, Chen G, Xing H, Wang C, Li K, Chen Y, Mao Y, Hu D, Pan Z, Chen Q, Cui B, Song K, Yi C, Peng G, Han X, An R, Fan L, Wang W, Xiong T, Chen Y, Tang Z, Li L, Yang X, Cheng X, Lu W, Wang H, Kong B, Xie X, Ma D. Weng D, et al. Front Med. 2023 Feb;17(1):93-104. doi: 10.1007/s11684-021-0892-z. Epub 2022 Nov 23. Front Med. 2023. PMID: 36422763 Free PMC article. Clinical Trial.
Chemical profiling and investigation of molecular mechanisms underlying anti-hepatocellular carcinoma activity of extracts from Polygonum perfoliatum L.
Tang X, Liu L, Li Y, Hao S, Zhao Y, Wu X, Li M, Chen Y, Deng S, Gou S, Cai D, Chen M, Li X, Sun Y, Gu L, Li W, Wang F, Zhang Z, Yao L, Shen J, Xiao Z, Du F. Tang X, et al. Biomed Pharmacother. 2023 Oct;166:115315. doi: 10.1016/j.biopha.2023.115315. Epub 2023 Aug 12. Biomed Pharmacother. 2023. PMID: 37579693 Free article.
Both in vitro and in vivo experiments confirmed that PPLA, along with its constituting compounds taxifolin, myricetin, and eriodictyol, exhibit potent anti-cancer activities and hold the promise of being developed into therapeutic agents....
Both in vitro and in vivo experiments confirmed that PPLA, along with its constituting compounds taxifolin, myricetin, and eriodictyol, exhi …
Retrospective analysis of 73 cases of elastofibroma.
Haihua R, Xiaobing W, Jie P, Xinxin H. Haihua R, et al. Ann R Coll Surg Engl. 2020 Feb;102(2):84-93. doi: 10.1308/rcsann.2019.0089. Epub 2019 Jun 24. Ann R Coll Surg Engl. 2020. PMID: 31233334 Free PMC article.
Modeling human hypertrophic scars with 3D preformed cellular aggregates bioprinting.
Bin Y, Dongzhen Z, Xiaoli C, Jirigala E, Wei S, Zhao L, Tian H, Ping Z, Jianjun L, Yuzhen W, Yijie Z, Xiaobing F, Sha H. Bin Y, et al. Bioact Mater. 2021 Sep 8;10:247-254. doi: 10.1016/j.bioactmat.2021.09.004. eCollection 2022 Apr. Bioact Mater. 2021. PMID: 34901543 Free PMC article.
The therapeutic interventions of human hypertrophic scars (HHS) remain puzzle largely due to the lack of accepted models. ...We also use the in vitro and in vivo models to define the clinically observed effects to treatment with concurrent anti-scarring drugs, and the data …
The therapeutic interventions of human hypertrophic scars (HHS) remain puzzle largely due to the lack of accepted models. ...We also …
Clinical, genetic profile and therapy evaluation of 55 children and 5 adults with sitosterolemia.
Xia Y, Duan Y, Zheng W, Liang L, Zhang H, Luo X, Gu X, Sun Y, Xiao B, Qiu W. Xia Y, et al. J Clin Lipidol. 2022 Jan-Feb;16(1):40-51. doi: 10.1016/j.jacl.2021.11.015. Epub 2021 Dec 6. J Clin Lipidol. 2022. PMID: 34969652
OBJECTIVE: To describe and compare the clinical, biochemical, genetic, therapeutic, and follow-up characteristics of 55 pediatric and five adult sitosterolemia patients. METHODS: Clinical, genetic and therapeutic data from 60 patients at Xinhua Hospital from January …
OBJECTIVE: To describe and compare the clinical, biochemical, genetic, therapeutic, and follow-up characteristics of 55 pediatric and …
Clinical and genetic characteristics of 42 Chinese paediatric patients with X-linked adrenal hypoplasia congenita.
Zheng W, Duan Y, Xia Y, Liang L, Gong Z, Wang R, Lu D, Zhang K, Yang Y, Sun Y, Zhang H, Han L, Gong Z, Xiao B, Qiu W. Zheng W, et al. Orphanet J Rare Dis. 2023 May 26;18(1):126. doi: 10.1186/s13023-023-02737-y. Orphanet J Rare Dis. 2023. PMID: 37237297 Free PMC article.
BACKGROUND: X-linked adrenal hypoplasia congenita (AHC) is a rare disorder characterized by primary adrenal insufficiency (PAI) and hypogonadotropic hypogonadism (HH), with limited clinical and genetic characterization. METHODS: The clinical, biochemical, genetic, therapeutic
BACKGROUND: X-linked adrenal hypoplasia congenita (AHC) is a rare disorder characterized by primary adrenal insufficiency (PAI) and hypogona …
IGF-1R/β-catenin signaling axis is involved in type 2 diabetic osteoporosis.
Zhang ZD, Ren H, Wang WX, Shen GY, Huang JJ, Zhan MQ, Tang JJ, Yu X, Zhang YZ, Liang D, Yang ZD, Jiang XB. Zhang ZD, et al. J Zhejiang Univ Sci B. 2019 Oct.;20(10):838-848. doi: 10.1631/jzus.B1800648. J Zhejiang Univ Sci B. 2019. PMID: 31489803 Free PMC article.
Our results suggest that the IGF-1R/beta-catenin signaling axis plays a role in the pathogenesis of DOP. This may contribute to development of the underlying therapeutic target for DOP....
Our results suggest that the IGF-1R/beta-catenin signaling axis plays a role in the pathogenesis of DOP. This may contribute to development …
20 results